ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 07:38 (2362 d 15:43 ago) – Posting: # 17945
Views: 9,206

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,671 registered users;
76 visitors (0 registered, 76 guests [including 4 identified bots]).
Forum time: 00:22 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5